The ERK MAPK pathway in mesenchymal glioblastoma: tumorigenesis, microenvironmental reprogramming, and the therapeutic promise of RAS(ON) multi-selective inhibition.

Rasonque (daraxonrasib) - Revolution Medicines

http://www.ncbi.nlm.nih.gov/pubmed/42683315

Ana González-Manteiga; Damir Garcia; Emily Haugen; Joseph Donohoe; Marc Oria; Mary M Fitzpatric; Mathieu Sertorio; Shashank Obulasetti; Uma M Basole; William Snider

Sep 3, 2026